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Abstract
Background. Calcitonin (CT) is known to affect renal Ca2+
handling. However, it remains unclear how CT affects Ca2+
transport in the distal convolutions. The aim of this study
was to investigate the contribution of the renal epithelial
Ca2+ channel, transient receptor potential vanilloid 5
(TRPV5), to renal Ca2+ handling in response to CT.
Methods. C57BL/6mice received a single overnight (16 hr)
injection of CT. In addition, TRPV5 knockout (TRPV5−/−)
mice and their wild type (TRPV5+/+) controls, received
three bolus injections of CT over a 40 hr study period. All
experimental groups were placed in metabolic cages.
Results. C57BL/6 mice received a single bolus injection of
CT, which significantly reduced the urinary Ca2+ excretion.
In addition, urinaryNa+ andK+ excretion also decreased after
CT administration. No apparent changes in renal expression
of TRPV5, calbindin-D28K (CaBP28K) or TRPV6 could be
detected between CT- and vehicle-treated mice. To evaluate
whether TRPV5 activity is needed for the CT-induced in-
crease in Ca2+ reabsorption, mice with genetic ablation of
TRPV5 (TRPV5−/−) were employed. TRPV5−/−mice as well
as their wild-type (TRPV5+/+) controls received three bolus
injections of CT over a 40-hr study period. Overnight
(16 hrs) as well as the subsequent 24-hr urine was collected.
Overnight urinary Ca2+ excretion was reduced in both
TRPV5−/− and TRPV5+/+ mice after a bolus injection of
CT. The subsequent 24-hr urinary excretion of Ca2+ which
was collected after the third bolus injection showed no effect
of CT on renal Ca2+ handling in either mice group. Accord-
ingly, CT did not alter the intrarenal protein abundance of
TRPV5 and CaBP28K after three bolus injections of CT.
Conclusion. CT augments the renal reabsorptive capacity
for Ca2+. This increase is likely to occur independently of
TRPV5.
Keywords: calbindin; calcitonin; calcium; distal convoluted tubule;
TRPV5
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Disturbances in the systemic Ca2+ concentration often result
in instability of the neurological and cardiac systems (e.g.
hypercalcaemia causes fatigue, nausea and abnormal heart
rhythms [1]). Thus, maintenance of serum Ca2+ concentra-
tion plays an important role in stabilizing these physiological
processes. Several hormones have been known to affect the
systemic Ca2+ concentration. Calcitonin (CT) is a 32 amino
acid peptide synthesized by post-translational processing in
the C cells of the thyroid gland in mammals [2]. CTacts pri-
marily by inhibiting osteoclast-mediated bone resorption
and is secreted in response to increases in systemicCa2+ con-
centration [2]. Historically, CT has been extensively used in
treating hypercalcaemia, osteoporosis and Paget's disease
[2]. Throughout the kidney and elsewhere, CTacts primarily
by activating the adenylate cyclase pathway [3,4].
In the kidney, vectorial NaCl transport within the thick as-
cending limb (TAL) drives paracellular transport of Ca2+.
Administration of CT to rats increases the renal reabsorp-
tion of Ca2+, which is in part achieved by increasing the re-
absorption of Ca2+ in the TAL. Here, application of CTalso
increases vectorial NaCl transport [5–7]. Active transcellu-
lar Ca2+ transport is restricted to the distal convolutions.
Here, luminal Ca2+ enters across the apical membrane via
the epithelial Ca2+ channel, transient receptor potential va-
nilloid 5 (TRPV5) [8,9]. Studies in rabbit suggest that CT
exerts its effect on Ca2+ reabsorption only in the distal con-
voluted tubule (DCT), while no stimulation occurs in the
connecting tubule (CNT) [10]. In addition, CT fails to stim-
ulate cyclic adenosine monophosphate (cAMP) accumula-
tion in the CNT of rabbits [11]. Our group has also been
unable to show stimulatory effects of CT on cAMP produc-
tion in rabbit primary CNT cultures [12]. In the rabbit,
TRPV5 localizes primarily to the CNTwhere CT does not
affect Ca2+ reabsorption [8,10]. However, inmouse, TRPV5
is highly expressed in apical membrane domains of partic-
ularly the late DCT2, with a gradual decrease along CNT
and initial collecting duct (iCD) [13,14], suggesting that
TRPV5-mediated Ca2+ uptake predominates in the DCT2
segment. Similarly, in rat, immunohistochemical data sug-
gests that TRPV5 expression appears in the DCT2 and is
further observed in the CNT [15]. The intrarenal distribu-
tion of TRPV5 in human is currently not known.
In comparison to rabbit, the boundaries defining the
DCT/CNT/iCD regions in human, rat and mouse are mor-
phologically less well defined, with cell types from differ-
ent segments intermingled. In the kidney of rats, the
‘bright’ portion of the DCT retains responsiveness to CT,
resulting in increased cAMP production [4]. CT-binding
sites have been identified in the rat kidney, including the
TAL and DCT [16]. Detailed micropuncture studies per-
formed by Elalouf et al. investigated the effects of CT
on electrolyte transport in the distal tubules of rats de-
prived of vasopressin, parathyroid hormone (PTH) and
glucagon. Here, they demonstrated that NaCl, as well as
Ca2+ transport, was increased by CT infusion [17]. Other
cAMP-elevating hormones such as PTH affect TRPV5-
mediated Ca2+ transport. PTH supplementation to parathy-
roidectomized rats increases the expression of TRPV5,
independent of serum 1,25-dihydroxyvitamin D3 levels,
suggesting that perhaps intracellular elevations in cAMP
affect the abundance of TRPV5 [18]. In addition, cAMP
generation has been shown to increase TRPV5 single-chan-
nel activity via a protein kinase alpha-dependent mecha-
nism [19]. However, it is unclear whether there is a
functional overlap between PTH and CT in the DCT2 re-
gions of rats and mice, and whether the CT-induced in-
crease in cAMP could lead to a similar activation in the
DCT2 segment as PTH.
In order to better understand the molecular actions of CT
on overall renal Ca2+ balance and to delineate the potential
effects of CTon TRPV5-dependent Ca2+ reabsorption, sev-
eral experimental series were performed in wild-type and
TRPV5-deficient mice. Due to the rapid action of CT, we




Male C57BL/6 mice (12 weeks of age) were housed in a light and tem-
perature-controlled room with ad libitum access to deionized drinking wa-
ter and standard chow (0.28% (wt/wt) NaCl, 1.00% (wt/wt) Ca, 0.22%
(wt/wt) Mg; LabDiet, USA). Mice were injected subcutaneously with a
single dose of salmon CT (20 U/100 g bodyweight, Novartis Pharmaceu-
ticals, Taiwan, n = 6) or vehicle (n = 6) and placed in metabolic cages.
After 16 hrs, overnight urine was collected, and the animals were sacri-
ficed under halothane anaesthesia. Blood was obtained via orbital punc-
ture before cervical dislocation. The kidneys were dissected out and snap
frozen for RNA extraction. The animal ethics boards of the National De-
fense Medical Center (Taipei, Taiwan) approved all animal experimental
procedures.
Experimental protocol 2
TRPV5−/− mice were generated by targeted ablation of the TRPV5 gene
as described previously [20]. After acclimatization, TRPV5+/+ and
TRPV5−/− mice received salmon CT (20 U/100 g bodyweight, n = 6) or
vehicle (n = 6) in three subcutaneous bolus injections spaced over 40 hrs.
During this period, the micewere housed in metabolic cages. Overnight (16
hrs) urinewas collected during the period between the first and second dose
of CT. Subsequently, 24-h urine was collected during the remainder of the
study, where the mice received the last two injections. At the end of the
experiment, animals were killed under halothane anaesthesia, blood was
removed, and tissue samples were harvested for immunohistochemistry
and western blotting. The animal ethics board of the Radboud University
Nijmegen approved the animal experimental procedures.
Urine and serum analyses
Urine and serum concentrations of Ca2+ were analysed using a colorimetric
assay kit (Roche, Mannheim, Germany). Urine and serum concentrations of
Na+ and K+ were determined using an automated analyser (AU 5000 chem-
istry analyser, Olympus, Tokyo, Japan).
RNA extraction and quantitative real-time PCR
Total RNA was extracted from kidney using Trizol Total RNA Isolation
Reagent (Sigma, St Louis, MO, USA) as described previously [21]. The
obtained total RNAwas subjected to DNase treatment to prevent genomic
DNA contamination. Thereafter, 1.5 µg of total RNA was reverse tran-
scribed by Moloney murine leukaemia virus reverse transcriptase (Prome-
ga, Madison, WI, USA). The cDNA was used to determine intrarenal
mRNA expression levels of TRPV5, calbindin-D28K (CaBP28K) and
TRPV6 by quantitative real-time PCR, using the ABI Prism 7700 Se-
quence Detection System (PE Biosystems, Rotkreuz, Switzerland). The
expression level of the housekeeping gene hypoxanthine–guanine phos-
phoribosyl transferase (HPRT) was used as an internal control to normal-
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ize differences in RNA extractions and reverse transcription efficiencies.
The primers and fluorescent probes used are as previously described
(MDBIO, Taipei, Taiwan) [21,22].
Immunohistochemistry
Kidney tissue was immersion fixed in 1% (wt/vol) periodate–lysine–para-
formaldehyde for 2 hrs at room temperature, and subsequently incubated
overnight at 4°C in phosphate-buffered saline (PBS) containing 15% (wt/
vol) sucrose. The kidneys were snap frozen in liquid nitrogen and 7-μm sec-
tions cut on a cryostat microtome (MicromHM550,MICROM International
GmbH, Germany). For immunohistochemical detection of TRPV5, kidney
sections were stained with a guinea pig anti-TRPV5 antibody (1:50) [8] or
mouse anti-CaBP28K antibody (1:1000; Sigma). To visualize TRPV5 and
CaBP28K, sections were stained with goat anti-guinea pig Alexa 488-conju-
gated anti-IgG (1:300; Sigma) and goat anti-mouse Alexa 488-conjugated
anti-IgG (1:300; Sigma), respectively. TRPV5 protein expression was
semi-quantified by taking five digital images of each kidney section on with
a Zeiss Axioskop microscope (Carl Zeiss, Inc., Thornwood, NY, USA) and
calculating the integrated optical density using Image-Pro Plus version 3.0
software (Media Cybernetics, Silver Spring, MD).
Immunoblotting
Total mouse kidney lysates were prepared as described previously [23]. The
protein concentration of the homogenateswas determinedwith the Bio-Rad
protein assay (Bio-Rad, München, Germany). Samples were submitted to
12% (wt/vol) SDS–PAGE and blotted to polyvinyldifluoride-nitrocellulose
membranes (Immobilon-P, Millipore Corp., Bedford, MA). Blots were in-
cubated overnight with a rabbit anti-CaBP28K polyclonal antibody
(1:5000; Sigma) at 4°C. Subsequently, blots were incubated with a goat an-
ti-rabbit peroxidase-labelled secondary antibody (1 hr; 1:10000; Sigma, St.
Louis, MO). Immunoreactive protein was detected by the chemilumines-
cence method (Pierce, Rockford, IL). Immunopositive bands were scanned
using an imaging densitometer (Bio-Rad Gs-690) to determine pixel den-
sity (Molecular Analyst Software; BioRad Laboratories, Hercules, CA).
Statistical analyses
Values are expressed as mean ± SEM. Statistical significance (P < 0.05)
in experimental protocol 1 was determined using the student's t-test. In
experimental group 2, significance was determined by a one-way ANO-
VA. In case of significance, the Tukey–Kramer multiple comparisons test
was applied. The analyses were performed using the Statview Statistical
Package Software (Power PC, version 4.51, Berkeley, CA).
Results
CT increases renal Ca2+ reabsorption in C57BL/6 mice
To assess the acute effects of CT, 16-hr urine from overnight
collections was obtained following a bolus injection of the
hormone (20 U/100 g body weight) or vehicle, respectively.
The effect of overnight CT exposure on renal and systemic
Ca2+ handling is depicted in Figure 1. Administration of CT
resulted in a significant decrease in the urinary excretion of
Ca2+ (P < 0.05). Serum Ca2+ concentrations were slightly
reduced after overnight CT administration (P < 0.05). Uri-
nary excretion of Na+ and K+ showed a significant decrease
after CT injection (Table 1). In addition, the urinary Na+/K+
ratio remained unchanged excluding an effect on the col-
lecting duct. These data are consistent with a primary effect
of CTon electrolyte transport in the TAL andDCT [5–7,17].
CT does not change the renal mRNA expression of TRPV5,
CaBP28K and TRPV6
To evaluatewhether the increased Ca2+ reabsorption could in
part be due to transcriptional changes in Ca2+ transport pro-
teins located in the distal convolutions, quantitative real-time
PCR was used to estimate TRPV5, CaBP28K and TRPV6
abundance. As can be seen in Figure 2, no changes were ob-
served in the renal mRNA expression of these transcripts. Al-
though CT did not modulate the changes of TRPV5, it does
not exclude the potential involvement of TRPV5. Therefore,
we investigated the effect of CT in TRPV5+/+ and TRPV5−/−
mice after one and three injections of CT.
CT stimulates Ca2+ reabsorption in TRPV5−/− mice
Administration of CT to TRPV5+/+ and TRPV5−/− mice re-
sulted in a decreased overnight urinary Ca2+ excretion in both
groups.However, after repeated administration ofCT, the uri-
nary Ca2+ excretion returned to normal in both TRPV5+/+
and TRPV5−/−mice, as compared to their corresponding ve-
Fig. 1. Renal Ca2+ excretion (A) and serum Ca2+ concentration (B) after a
bolus injection CT (data is presented as mean ± SEM; *P < 0.05,
statistically significant.
Table 1. Serum concentrations and urinary excretion of Na+ and K+ after a bolus injection CT
Urine Serum
Volume (ml) Na+ (μmol) K+ (μmol) Na+/K+ ratio Na+ (mM) K+ (mM)
Control 1.21 ± 0.11 268 ± 32 639 ± 30 0.42 ± 0.03 150 ± 0.4 5.34 ± 0.11
CT 0.98 ± 0.18 132 ± 16* 305 ± 50* 0.44 ± 0.02 152 ± 0.5 5.30 ± 0.03
*P < 0.05 versus controls; CT, calcitonin.
Data is presented as mean ± SEM. n = 6 animals per group. *P < 0.05, statistically significant.
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hicle-injected controls (Figure 3). SerumCa2+ concentrations
were measured after 40 hrs, but no difference was observed
after CT administration in either strain (Figure 3). This is in
line with the observed rapid effect of CT.
Renal protein expression of Ca2+ transporters remains
unaltered after three CT injections
Kidneys retrieved from TRPV5+/+ and TRPV5−/− mice by
the end of the experiment were used to assess the effects of
CT on renal Ca2+ transporter expression. TRPV5 and
CaBP28K protein abundance was semi-quantified by
immunohistochemistry (Figure 4) and immunoblotting
(Figure 5), respectively. Computerized analysis of immuno-
histochemical images did not reveal any changes in TRPV5
protein expression after CT administration in TRPV5+/+
mice compared to their vehicle-injected control TRPV5+/+
mice (Figure 4). This is in line with the observation that CT
affects renal Ca2+ transport independent of TRPV5. In ad-
dition, the renal CaBP28K protein expression remained un-
changed after CT administration in TRPV5− /− mice
(Figure 4 and 5). The CaBP28K protein expression of
TRPV5−/− mice was significantly reduced compared to
TRPV5+/+ mice [20] (Figure 4 and 5).
Fig. 3. Renal Ca2+ excretion after one and three bolus injections spaced over 40 hrs in TRPV5+/+ and TRPV5−/− mice [16 hrs urinary Ca2+ excretion
after a single bolus injection of CT (A) and the consecutive 24 hrs of urinary Ca2+ excretion after three injections (B); serum Ca2+ concentrations after
three CT bolus injections spaced over 40 hrs (C); data is presented as mean ± SEM. *P < 0.05, statistically significant].
Fig. 2. mRNA expression of TRPV5, CaBP28K and TRPV6 after overnight bolus injection of CT [representative histograms of mRNA expression of
TRPV5 (A), CaBP28K (B) and TRPV6 (C) in kidney; data are presented as mean ± SEM].
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Abolus injection of CT significantly reduced the urinary ex-
cretion of Ca2+ in wild-type mice. This decrease was associ-
ated with a reduction in the urinary Na+ and K+ excretion,
leaving the urinary Na+/K+ ratio unchanged. These data
are consistent with the previously reported effects of CT
on stimulating TAL and DCT transport of NaCl and K+
[6,7,17,24]. Earlier studies in the TAL of mice and rats have
demonstrated that CT activates NaCl transport only in the
cortical TAL [6,24]. This segment of the TAL is also thought
to drive paracellular Ca2+ reabsorption in these species. Al-
Fig. 4. Immunohistochemical staining of renal Ca2+ transporters after three bolus injections in TRPV5+/+ and TRPV5−/− mice [representative images of
immunohistochemical staining of TRPV5 (A) and CaBP28K (B) in kidney cortex; semi-quantification of renal TRPV5 (C) and CaBP28K (D) protein
abundance was performed by computerized analysis of immunohistochemical images; data were calculated as integrated optical density (IOD; arbitrary
units) and depicted as percentage of TRPV5+/+ controls; *P < 0.05, statistically significant; data is presented as mean ± SEM; n = 6 animals per group].
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though never delineated in detail, CT is likely to activate a
cAMP cascade leading to increased NKCC2 transport, per-
haps via increased membrane trafficking and phosphoryla-
tion [5,6,25]. Currently, it remains unknown which
transporter CT stimulates in the DCT [17]. One option is
the thiazide-sensitive NaCl cotransporter that resides there.
A significant, albeit small, change in serum Ca2+ con-
centrations was observed after overnight CT administra-
tion. Earlier reports show that infusion of CT, depending
on dose, acutely reduces serum Ca2+ concentrations that
frequently revert to normal range within 1 day [26]. In line
with this, no change was observed in systemic Ca2+ con-
centrations after three injections of CT spaced over 40 hrs.
One may suggest that the reduced excretion of Ca2+ in the
?twb=.27w?>presence of CT occurs to compensate for the
acute surge in systemic Ca2+ concentrations normally as-
sociated with CT administration. However, in thyropar-
athyroidectomized (TPTX) rats, Ca2+ infusion prior to
CT treatment was given in order to avoid hypocalcaemia
in the animals. In these TPTX rats, CTwas still able to re-
duce the fractional excretion of Ca2+ despite normocalcae-
mia [27]. This is consistent with a direct effect of CT on
the kidney. The effect of CT on urinary Ca2+ excretion is
also absent after repeated administration of CT to either
TRPV5+/+ or TRPV5−/− mice. Reduced surface expression
of CT receptors and decreased mRNA expression has been
shown to explain such escape phenomena in other cell
types [28]. This may also explain why patients with a
CT-secreting tumour frequently have normal systemic con-
centrations of Ca2+ [29].
The present study was initiated to investigate the poten-
tial effect of CT on TRPV5-mediated Ca2+ reabsorption.
Injections of CT for 16 or 40 hrs did not change the renal
abundance of TRPV5. In addition, TRPV5+/+ and
Fig. 5. Effects of CT on renal CaBP28K protein expression in TRPV5+/+ and TRPV5−/− mice. Immunoblots of protein samples (10 μg each) from
homogenates of kidney tissue were labelled with antibodies against CaBP28K (A). Expression of CaBP28K protein was quantified by computer-
assisted densitometry analysis and presented as the ratio to β-actin expression levels in relative percentages (B). Data are presented as mean ±
SEM. *P < 0.05, statistically significant; n = 6 animals per group.
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TRPV5−/− mice responded in a similar manner to CT ad-
ministration. Given the data obtained in these experimental
models, it is likely that the effect of CT on renal Ca2+
transport occurs independently of TRPV5. Although CT
does not affect TRPV5-mediated Ca2+ reabsorption, it is
clear from this study that CT strongly stimulates renal
Ca2+ reabsorption. The stimulatory effect of CT is likely
to occur primarily through changes in Ca2+ transport, as
previously described [6,7,24]. It should be stated that al-
though the effects of CT on renal Ca2+ transport are present
in TRPV5+/+ as well as in TRPV5−/−mice, and that TRPV5
expression is unaltered after CTadministration, this does not
fully exclude an effect upon TRPV5. Although unlikely, a
lack of stimulation of CT on TRPV5 in TRPV5−/− mice
may be masked due to the pronounced effect of CT in the
TAL. TRPV6 is a highly selective Ca2+ channel which has
been localized to apical membrane domains in kidney [30].
As TRPV6may play a role in apical Ca2+ entry of tubules in
the distal part of the nephron,mRNAabundance of the chan-
nel was determined after an overnight bolus injection of CT.
Administration of CT did not change the expression level of
renal TRPV6. These data indicate that the effect of CTon re-
nal Ca2+ transport occurs independently of TRPV6.
In the rat, CT has been shown to increase NaCl as well
as Ca2+ transport in the DCT [17], thus vectorial transfer of
Ca2+ does occur to a greater extent in the presence of CT.
The present study suggests that these effects occur largely
independent of TRPV5. In addition, microperfusion ex-
periments in rabbits show that CT stimulates Ca2+ trans-
port in the early DCT, where TRPV5 is not expressed
[10]. This raises the question, how does Ca2+ transport oc-
curs in the early DCT and does it contribute significantly
to overall renal Ca2+ handling? Further studies are needed
to determine the potential effect of CT on electrolyte trans-
porters in these segments.
In conclusion, overnight CT administration increases re-
nal Ca2+ reabsorption in mice. This effect occurs indepen-
dently of TRPV5 as no change can be detected in TRPV5
and CaBP28K expression and similar responses to CT is
observed in TRPV5+/+ and TRPV5−/− mice.
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Abstract
Background. Rhabdomyolysis-induced acute kidney in-
jury (AKI) accounts for about 10 to 40% of all cases
of AKI. It is known that N-acetylcysteine (NAC) is ef-
fective in various experimental renal injury models; how-
ever, little information is available about the rat model of
glycerol-induced rhabdomyolysis. In this study, we hy-
pothesize that NAC plays a renoprotective role via the
anti-apoptotic pathway.
Methods.Male Sprague-Dawley rats were divided into four
groups: (i) saline control group, (ii) NAC-treated group (N-
acetylcysteine) (150 mg/kg), (iii) glycerol-treated group
(50%, 8ml/kg, IM) and (iv) NAC plus glycerol-treated
group. Rats were sacrificed at 24 h after glycerol injection,
and the blood and renal tissues were harvested.
Results. Glycerol administration caused severe renal dys-
function, which included marked renal oxidative stress, sig-
nificantly increased blood urea nitrogen (BUN) and serum
creatinine levels. Histopathological findings, such as cast
formation and tubular necrosis, confirmed renal impair-
ment. We noted a marked activation of extracellular
signal-regulated kinase (ERK) and c-Jun N-terminal kinase
(JNK), but not p-38, in the glycerol-treated group. We also
observed high expression of Bax and Bad but only weak
expression of Bcl-2 and Bcl-xL in the glycerol-treated
group. However, NAC pretreatment significantly improved
renal function and decreased the activation of ERK, JNK,
Bax and Bad, whereas it increased Bcl-2 and Bcl-xL.
Conclusion. These results demonstrate that NAC protects
against renal dysfunction, morphological damage and bio-
chemical changes via the anti-apoptotic pathway in the
glycerol-induced rhabdomyolysis model in rats.
Keywords: acute kidney injury; Bcl-2 family proteins; MAPKs;
N-acetylcysteine; rhabdomyolysis
Introduction
Rhabdomyolysis is a syndrome involving the breakdown
of skeletal muscle, which causes myoglobin and other in-
tracellular proteins and electrolytes to leak into the circu-
lation [1]. It is often complicated by acute kidney injury
(AKI), electrolyte imbalance and disseminated intravascu-
lar coagulation. About 10 to 50% of patients suffering
from significant rhabdomyolysis develop some degree of
AKI [2]. Although the treatment has been much improved,
the mortality rate may still be as high as 8% [1,3,4]. The
experimental model for rhabdomyolysis is easily acquired
by injecting glycerol intramuscularly into rats or mice [5].
AKI by rhabdomyolysis has three pathogenic mechan-
isms: tubular obstruction, renal vasoconstriction and oxida-
tive stress. Oxidative stress has been an important target in
the prevention of myoglobin-induced renal injury [6]. The
administration of antioxidants has been shown to provide
partial protection against myoglobinuric-induced AKI [7–
11]. N-acetylcysteine (NAC), one of these antioxidants, is
a source of sulfhydryl and glutathione (GSH) groups in cells
and, due to its interaction with reactive oxygen species, is a
scavenger of free radicals [12]. The protective effect of NAC
with respect to renal injury has been proven in various mod-
els, such as cisplatin [13], ischaemia–reperfusion injury
[14,15] and chronic kidney disease [16]. However, there
is little data for administering NAC in the rhabdomyolysis
model, and the results are controversial [17,18].
NAC effect on rhabdomyolysis model 1435
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